medigraphic.com
Boletín Clínico de la Asociación Médica del Hospital Infantil del Estado de Sonora

2010, Number 1

<< Back Next >>

Bol Clin Hosp Infant Edo Son 2010; 27 (1)

Reflujo Vesico-Vaginal Asociado a Vulvovaginitis Crónica en Pediatría

López-Cruz G, Sosa-Vásquez J, Paulo-Antunez F, Morales-García J

Language: Spanish
References: 42
Page: 16-21
PDF size: 143.84 Kb.


ABSTRACT

Introduction: In children the vulvovaginal infection, in 70% is due to poor personal hygiene. The vesicovaginal reflux as possible factor of vulvovaginitis in paediatrics is controversial. Due to the interaction of molecular mechanisms of defense against urinary infection; the presence of vesicovaginal reflux can take different connotations, like in the series of patients reported here with important clinical manifestations.
Material and Methods: Observational prospective study, not randomized; from 1° January 2004 thru 31 December of 2007. In patients with chronic vulvovaginitis. In the paediatric urologic consultation of the health sector and private practice.
Results: Of the 12 patients with chronic vulvovaginitis. 10 (83,35%) cases completed the studies. In 8 (66,6%) cases vesicovaginal reflux by ultrasound was observed; in 9 (75%) vesicovaginal reflux was documented by miccional cistography
Conclusions: The present article reports the association between vesicovaginal reflux to chronic vulvovaginitis. Not reported in national paediatric literature as a possible factor of chronic vulvovaginitis.


REFERENCES

  1. Romero FP. Vulvovaginitis en niñas y adolecentes. Rev Chil Pediatr (revista en internet) 70(3): 242-7.

  2. Escobar ME. Recomendaciones para el diagnostico y tratamiento de vulvovaginitis en niñas prepúberes. Comité Nacional de endocrinología. Arch Argent Pediatr 2000; 98(6): 412.

  3. Cob SC, Castañeda NJ, Diez MG. Vulvovaginitis en González SN Infectología clínica pediátrica. Quinta edición, México: editorial trillas, 1993: Cap. 13 pág. 282-8.

  4. Comités de la SAP. Recomendaciones para el diagnostico y tratamiento de la vulvovaginitis (VV) en niñas prepúberes. Comité nacional de endocrinología. Arch Argent Pediatr. 2000; 98(6): 412-4.

  5. Cuadros J, Mazón A, Martínez R, González P, Gil SA, Flores U, Orden B, Gómez HP, Millan R. The aetiology of paediatric inflammatory vulvovaginitis. Eur J Pedatr.2004; 105-7.

  6. Lòpez CG, Reyes HD, Galván EH, Reyes HU, Reyes GU. Bacteriología de la vulvovaginitis en pediatría. Bol Clin Hosp Infant Son. 2007, 24(2): 56-61.

  7. Sanchez JA, Coyotécatl LL, Enríquez MA, Mendoza E, Muñoz G, Rivera JA. Incidencia del bacilo de Döderlein y su influencia en la presencia de otros microorganismos en el canal vaginal. Univ Méd Bogotá. 2008; 49(2): 172-9.

  8. Laspina F, Samudio M, Céspedes AM, González GM, Balmaceda MA. Agentes etiológicos de la vulvovaginitis en niñas. Mem Inst Investig Cienc Salud. 2005; 3(1): 9-14.

  9. Fernández CVM. Vulvovaginitis. 2008 (2). Guía ABE infecciones en pediatría. http://infodoctor.org7gipi/guia_abe/

  10. Garcia JF, Schneider J, Ponton J. Vulvovaginitis candidiasica. Med Clin (Barc). 1994; 103: 505-8.

  11. Laspina F, Samudio M, Céspedes AM, González GM, Balmaceda MA. Agentes etiológicos de vulvovaginitis en niñas. Mem Inst Investig Cienc Salud. 2005; 3(1): 9-14.

  12. Pimentel SB, Reynolds ME. Candidiasis vaginal. Rev Paceña Med Fam. 2007; 4(6):121-7.

  13. García-Alvarez R, Acedo Garcia H, Limón-Cota A. Infección de vías urinarias y su posible relación con desviación de orina hacia vagina durante la micción. Bol Med Hosp Infant Mex. 1988; 45(11):792-4.

  14. Pompinoi HJ, Hoffman D. Anormalies of the externals urethral orificie in girls. Prog Pediatr Surg. 1984; 17: 49-56.

  15. Kelalis PP, Burke EC, Stickler GB, Hartman GW. Urinary vaginal reflux in children. Pediatrics. 1973; 51(5): 941-3.

  16. García BC. Caso Nro 8_Facultad de Medicina Pontificia Universidad Católica de Chile. http://www.slarp.net/index.php#top.

  17. Svan borg-Eden C, Anderson B, Hogberg L, et al Receptor analogues and antipili antibodies as inhibitors of bacterial attachment in vivo in vitro. Ann Ny Acad Sci.1983; 409: 580.

  18. Schaeffer AJ, Radvany RM, Chiniel JS : Human leukocyte antigens in women with recurrent urinary tract infections. J infect Dis. 1983. 148-604.

  19. Lomberg H, Hanson LA, Jacobsson B et al. Correlation of P blood grup, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med.1983; 308:1189,

  20. Hopkin WJ, Heisey DM, Lorentzen DF, Vehling DT. A comparative study of mayor histocompatibility complexa n red blood cell antigen phenotypes as risk factors for recurrent urinary tract infections in womwn. J Infect Dis. 1998;177: 1296-301.

  21. Stapleton A Prevention of recurrent urinary tract infctions in women . Lancet. 1999; 353:7-8.

  22. Sabroe I, Read CR, Whyte MK,Dockrell DH, Vogel SN, Dower SK. Toll-like receptors in health and disease:complex questions remain. J Immunol. 2003; 1630-5.

  23. Weichhart T, Haidinger M, Hörl WH, Sáemann MD. Currente concepts of molecular defence mechanisms operative during urinary tract infection. Eur L Clin Invest. 2008; 38(2): 29-38.

  24. Ragnarsdóttir B, Fischer H, Godaly G. TRL- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections. Eur J Clin Invest. 2008; 38(2): 12-20.

  25. Kilicoglu C, Aslan AR, Oztürk M, Karaman IM, Simsek MM. Vesicovaginal reflux: Recognition and diagnosis using ultrasound. Pediatr Radiol. 2009; (Epud Ahead of print).

  26. Paulica P, Gaudiano C, Barozzil L. Sonography of the bladder. Word J Urol. 2004; 22: 328-34.

  27. Ortiz QF Salud en la pobreza. El proceso salud-enfermedad en el tercer mundo. México DF: Editorial Nueva Imagen, 1982:96.

  28. Gomezjara F, Ávila JR, Morales RM. Salud comunitaria: Teoría y Técnicas. México DF: Ediciones nueva sociología. 1983:689

  29. Ramírez GA. Humanismo y medicina. Oaxaca México. 1994: 196.

  30. Spigarelli MG. Urine gonococcal/chlamydia testing in adolescents. Curr Opin Obstet Gynecol. 2006; 18(5): 498-502.

  31. Shapiro RA, Schubert CJ, Myers PA. Vaginal discharge as an indicador of gonorrhea and chlamydia infection in girls under 12 year old. Pediatr Emerg Care. 1993; 9(6): 341-5.

  32. Fang J, Husman C, De Silva L, Chang R, Peralta L. Evaluation of self-collected vaginal swab, first void urine, and endocervical swad specimens for the detection of chlamydia trachomatis and neisseria gonorrhoeae in adolescente females. J Pediatr Adolesc Gynecol. 2008; 21(6):355-360

  33. Cook RL,Hutchison SL, Ostergaard L, Braithwaite RS, Ness RB. Systematic review: noninvasive testing for chlamydia trachomatis and neisseria gonorrhoeae. Ann Intern Med. 2005; 142(11): 914-25.

  34. Muram D, Speck PM, Dockter M. Child sexual abuse examination: is the a need for Soutine screening for N. gonorrhoeae? J Pediatr Adolesc Gynecol. 1996; 9(2): 79-80.

  35. Herman-Giddens ME. Vaginal foreing bodies and child sexual abuse. Arch Pediatr Adolesc Med. 1994; 148(2): 195-200.

  36. Ortiz ZM, González PA, Dávila RM, Valencia GC. Frecuencia de vaginosis en niñas y adolescentes en un centro de medicina familiar. Rev Mex Pediatr. 2008; 75(6): 257-60.

  37. Barbosa RG, Sánchez DP. Vulvovaginitis en la prepuber. Rev Chil Obstet Ginecol. 2005; 70(2): 99-102.

  38. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immun. 1997; 65: 3451-6.

  39. Poltorak A, HeX, Smirnova I et al. Defective LPs signaling in C3H/HejandC57BL/10ScCr mice mutations in Tlr4 gene. Science, 1998; 282: 2085-8.

  40. Qureshi ST, Lariviere L, Leveque G, et al. Endotoxin tolernace mice have mutations in toll-like receptor 4 (Tlr4). J Exp Med. 1999; 189: 615-25.

  41. Ronald A. The etiology of urinary tract infection: traditional and emerging pathoegens. Dis Mon. 2003; 49:71-82.

  42. Korber T. El médico del emperador. Editorial Ediciones B, 2005: 576.




2020     |     www.medigraphic.com